⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Stock Market News For Jan 23, 2018

Published 01/22/2018, 09:54 PM
Updated 07/09/2023, 06:31 AM
US500
-
DJI
-
AMZN
-
CELG
-
AIG
-
NFLX
-
IXIC
-
SNY
-
XLE
-
VIX
-
SB9
-
BIVV
-

Major benchmarks hit record highs on Monday after the Senate gave its consent to pass a Bill that ends the current government shutdown. Meanwhile, biotech sector rallied following major biotech merger deals. This led the Nasdaq higher which ended at a record. The Dow and the S&P also ended in record territory.

The Dow Jones Industrial Average (DJI) increased 0.6%, to close at 26,214.60. The S&P 500 rose 0.8% to close at 2,832.97. The tech-laden Nasdaq Composite Index closed at 7,408.03, gaining 1%. The fear-gauge CBOE Volatility Index (VIX) decreased 3.6% to close at 10.87. A total of around 6.56 billion shares were traded on Monday, higher than the last 20-session average of 6.34 billion shares. Advancers outnumbered decliners on the NYSE by a 1.70-to-1 ratio. On Nasdaq, a 1.38-to-1 ratio favored advancing issues.

Biotech ETF Surges, Pushes Nasdaq Higher

The iShares Nasdaq Biotechnology ETF (IBB) surged 3.1% on Monday following a couple of merger deals in the biotech sector worth billions of dollars. Touted to be the largest biotech ETF, iShares Nasdaq Biotechnology is trading at its highest levels since October 2017.

Shares of Juno Therapeutics, Inc. (NASDAQ:JUNO) skyrocketed 26.8% on Monday after it entered into an agreement with Celgene Corp. (NASDAQ:CELG) to be purchased for a whopping $9 billion. In other deal news, Bioverativ Inc. (NASDAQ:BIVV) agreed to purchase Sanofi (NYSE:SNY) for $12 billion. Following such news, shares of Bioverativ rallied 63%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

These developments led to broad based gains for the biotech sector and also pushed the Nasdaq higher. The tech-laden index surged 71.7 points to end the session at an all-time high. Gains for Nasdaq were further supported by a surge of 3.2% in the shares of Netflix (NASDAQ:NFLX) .

Dow and S&P 500 Post Record Closes

The S&P 500 gained 22.7 points to hit a record high. Of the 11 major segments of the S&P 500, 10 ended in the green, with consumer discretionary shares leading the advancers. The Energy Select Sector SPDR ETF (NYSE:XLE) and Consumer Discret Sel Sect SPDR ETF (XLY) gained 2.2% and 1.1%, respectively.

The Dow amassed 142.9 points to finish at a record close. Such gains were rather broad based and followed the Senate’s decision to approve a bill that would end the government shutdown.

Senate Approves a Bill to Prevent Shutdown

On Monday, the Senate approved a Bill which paved way for the ongoing government shutdown to end. The House had already passed a one-month spending Bill on Jan 18 to keep the government funded up until Feb 16, 2018. However, the Bill did not find much favor in the Senate and therefore could not reach the 60-vote mark to clear the Senate. The Senate adjourned without further voting for a final outcome on Thursday.

The funding to keep the government funded ended on Saturday, leading to a shutdown. This shutdown stretched through Monday after lawmakers in the United States failed to reach a resolution on the issue. This was due to negotiations related to immigrations, discussions over which bothered the Republican-led Congress for most of Sunday.

Stocks That Made Headlines

AIG to Buy Validus, Expand Reach in Reinsurance Business

American International Group Inc. (NYSE:AIG) has agreed to buy Bermuda based reinsurer, Validus Holdings Ltd. (Validus). The deal should see light by mid-2018. (Read More)

Wall Street’s Next Amazon (NASDAQ:AMZN)

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



Netflix, Inc. (NFLX): Free Stock Analysis Report

Sanofi (SNY): Free Stock Analysis Report

American International Group, Inc. (AIG): Free Stock Analysis Report

Celgene Corporation (CELG): Free Stock Analysis Report

Juno Therapeutics, Inc. (JUNO): Free Stock Analysis Report

BIOVERATIV INC (BIVV): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.